China Cord Blood Corp. (NYSE:CO)’s share price was down 1.7% on Thursday . The company traded as low as $5.01 and last traded at $5.15, with a volume of 81,132 shares traded. The stock had previously closed at $5.24.

A number of equities analysts have recently weighed in on CO shares. Zacks Investment Research cut shares of China Cord Blood Corp. from a “hold” rating to a “sell” rating in a research note on Tuesday, July 12th. TheStreet cut shares of China Cord Blood Corp. from a “buy” rating to a “hold” rating in a research note on Thursday, August 4th. Five equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $7.00.

The firm has a market cap of $406.82 million and a PE ratio of 27.02. The company’s 50 day moving average price is $5.50 and its 200 day moving average price is $5.90.

China Cord Blood Corp. (NYSE:CO) last issued its quarterly earnings data on Tuesday, June 14th. The company reported $0.03 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.03. The company had revenue of $24.30 million for the quarter. Equities analysts anticipate that China Cord Blood Corp. will post $0.17 earnings per share for the current year.

China Cord Blood Corporation is principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. The Company provides cord blood testing, processing and storage services under the direction of subscribers. The Company also preserves cord blood units donated by the public, provides matching services on such donated units and delivers matching units to patients in need of transplants.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.